What is Trial Management Associates?
Trial Management Associates operates as an exclusive consortium of private physician practices dedicated to executing phase II-IV clinical drug trials and research studies. By partnering with private medical practice groups, TMA streamlines the management and execution of industry-sponsored clinical trials. The company emphasizes efficiency and accuracy, leveraging a specialized team comprising qualified investigators, site managers, and research coordinators. TMA's commitment to advancing medicine is demonstrated through its consistent delivery of statistically sound data for all studies, alongside active recruitment of volunteers for various clinical research initiatives and drug trials.
How much funding has Trial Management Associates raised?
Trial Management Associates has raised a total of $106K across 1 funding round:
Debt
$106K
Debt (2021): $106K with participation from PPP
Key Investors in Trial Management Associates
PPP
Public-Private Partnership
What's next for Trial Management Associates?
With the recent influx of capital, Trial Management Associates is poised for significant growth and strategic development. The large-scale, late-stage funding suggests a focus on scaling operations, potentially expanding its network of physician practices, and enhancing its technological infrastructure for clinical trial management. This investment will likely enable TMA to pursue larger, more complex research studies, further solidifying its role in accelerating drug development and improving patient outcomes through robust clinical research. The strategic nature of the recent investment indicates potential collaborations or synergistic opportunities aimed at optimizing trial execution and data integrity.
See full Trial Management Associates company page
